Research

Energy balance

There was no association found between weight loss and improvement in FEV1 or FVC.

Weight loss from GLP-1 therapies may not lead to improvements in lung function, indicating the need for further investigation.

StrongRefutesmedium confidence
There was no association found between weight loss and improvement in FEV1 or FVC.
Spenser E. January et al. · Clinical Transplantation · 2025

Why this rating

The study design is a single-center retrospective study with a defined patient population.

Source

Impact of GLP‐1 and GLP‐1/GIP Receptor Agonist Weight Loss Post‐Lung Transplant on Lung Allograft Function

Spenser E. January et al. · Clinical Transplantation · 2025

DOI 10.1111/ctr.70246

cohort · n=81Cited 3×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →